Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages

Cell Reports(2024)10.1016/j.celrep.2024.113942Source: DataRank Database

PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0. It has been cited 30 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access30 citations

Download PDF

Cite:

Linked data & code

geo gen pxd

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 4.86)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Ilona Kryczek ORCID,Hongjuan Zhang ORCID,Nisha Nagarsheth ORCID,Houjun Xia ORCID,Zhenyu Wu ORCID

Live enrichment

PubMed:38489266 PMC:PMC11022165 OpenAlex:https://openalex.org/W4392769596

NCI NIH HHS

Grant: R01 CA248430

NCI NIH HHS

Grant: R01 CA244827

NHLBI NIH HHS

Grant: R01 HL155116

NCI NIH HHS

Grant: R01 CA099985

NCI NIH HHS

Grant: R01 CA123088

NCI NIH HHS

Grant: R01 CA261985

NCI NIH HHS

Grant: R01 CA193136

NCI NIH HHS

Grant: P30 CA046592

NCI NIH HHS

Grant: R01 CA152470

NIH

FWCI

4.86

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124724002705/pdf

publisherhttp://www.cell.com/article/S2211124724002705/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124724002705?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124724002705?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2024.113942

Fields of Study

Immune cells in cancerImmune Cell Function and InteractionCancer Immunotherapy and BiomarkersMiceAnimalsProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 4HydrolasesProtein Processing, Post-TranslationalHistocompatibility Antigens Class IIMacrophages

MeSH Terms

Protein-Arginine DeiminasesProtein-Arginine Deiminase Type 4AnimalsHistocompatibility Antigens Class IIHydrolasesMacrophagesProtein Processing, Post-TranslationalMice

Keywords

ImmunityMHC class IIImmunologyCD74MHC class IMajor histocompatibility complexClass (philosophy)Immune systemBiologyCell biologyCancer researchChemistryMedicineComputer scienceTumorMacrophageImmunotherapySTAT1T cellMHCAntigen presentationcheckpointCitrullinationPad4PiasCp: ImmunologyCp: Cancer

Sustainable Development Goals

SDG 0: Good health and well-being

PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages

FAIR Checklist

Authors (18)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)